{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:24:41Z","timestamp":1791915881049,"version":"4.3.4"},"reference-count":61,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1001\/jamasurg.2020.2611","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T16:36:03Z","timestamp":1597854963000},"page":"970","source":"Crossref","is-referenced-by-count":20,"title":["Multidisciplinary Update on Genital Hidradenitis Suppurativa"],"prefix":"10.1001","volume":"155","author":[{"given":"Judy","family":"Hamad","sequence":"first","affiliation":[{"name":"University of North Carolina at Chapel Hill School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"McCormick","sequence":"additional","affiliation":[{"name":"Department of Urology, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Sayed","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Paci","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Overton","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Daubert","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley D.","family":"Figler","sequence":"additional","affiliation":[{"name":"Department of Urology, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"srv200006r1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States.","volume":"153","author":"Garg","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"4","key":"srv200006r2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa.","volume":"178","author":"Ingram","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"srv200006r3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part i: diagnosis, evaluation, and the use of complementary and procedural management.","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"srv200006r4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part ii: topical, intralesional, and systemic medical management.","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"srv200006r5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2340\/00015555-2176","article-title":"Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis.","volume":"95","author":"Vlassova","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"srv200006r6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","article-title":"Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota.","volume":"133","author":"Vazquez","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"1","key":"srv200006r7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","article-title":"Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis.","volume":"77","author":"Garg","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"srv200006r8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/ijd.13985","article-title":"A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa.","volume":"57","author":"Dessinioti","year":"2018","journal-title":"Int J Dermatol"},{"issue":"7","key":"srv200006r9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamadermatol.2019.0164","article-title":"Comparative overall comorbidity burden among patients with hidradenitis suppurativa.","volume":"155","author":"Reddy","year":"2019","journal-title":"JAMA Dermatol"},{"key":"srv200006r10","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.16603","article-title":"Profound consequences of hidradenitis suppurativa: a review.","author":"Matusiak","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"srv200006r11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jid.2017.06.020","article-title":"Patients with hidradenitis suppurativa have a high psychiatric disease burden: a Finnish nationwide registry study.","volume":"138","author":"Huilaja","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"6","key":"srv200006r12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"srv200006r13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","article-title":"Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity.","volume":"71","author":"Schrader","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"srv200006r14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jdermsci.2017.04.006","article-title":"A retrospective institutional study of the association of smoking with the severity of hidradenitis suppurativa.","volume":"87","author":"Dessinioti","year":"2017","journal-title":"J Dermatol Sci"},{"issue":"1","key":"srv200006r15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/DSS.0000000000000944","article-title":"Vulvar, perianal and perineal cancer after hidradenitis suppurativa: a systematic review and pooled analysis.","volume":"43","author":"Makris","year":"2017","journal-title":"Dermatol Surg"},{"issue":"9","key":"srv200006r16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jamadermatol.2018.2117","article-title":"Association of low socioeconomic status with hidradenitis suppurativa in the United States.","volume":"154","author":"Wertenteil","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"9","key":"srv200006r17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamadermatol.2014.691","article-title":"Health care utilization patterns and costs for patients with hidradenitis suppurativa.","volume":"150","author":"Kirby","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"2","key":"srv200006r18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project.","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"20","key":"srv200006r20","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment.","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA"},{"key":"srv200006r21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fimmu.2019.00302","article-title":"Commentary: hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model.","volume":"10","author":"Frew","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"srv200006r22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/bjd.12068","article-title":"Impaired Notch signalling: the unifying mechanism explaining the pathogenesis of hidradenitis suppurativa (acne inversa).","volume":"168","author":"Melnik","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"srv200006r23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/bjd.17426","article-title":"Complement, hidradenitis suppurativa and pathogen-driven positive selection.","volume":"180","author":"Frew","year":"2019","journal-title":"Br J Dermatol"},{"issue":"9","key":"srv200006r24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","article-title":"The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls.","volume":"153","author":"Ring","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"6007","key":"srv200006r25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1196284","article-title":"Gamma-secretase gene mutations in familial acne inversa.","volume":"330","author":"Wang","year":"2010","journal-title":"Science"},{"issue":"2","key":"srv200006r26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/bjd.14482","article-title":"Genetic analysis of NCSTN for potential association with hidradenitis suppurativa in familial and nonfamilial patients.","volume":"175","author":"Liu","year":"2016","journal-title":"Br J Dermatol"},{"issue":"1","key":"srv200006r27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2133.2010.09773.x","article-title":"Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.","volume":"163","author":"Esmann","year":"2010","journal-title":"Br J Dermatol"},{"issue":"4","key":"srv200006r28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"issue":"6","key":"srv200006r29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa.","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"srv200006r30","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2016.06.049","article-title":"Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series.","volume":"75","author":"Riis","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"srv200006r31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/ijd.13428","article-title":"Hidradenitis suppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients.","volume":"56","author":"Armyra","year":"2017","journal-title":"Int J Dermatol"},{"issue":"2","key":"srv200006r32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.","volume":"219","author":"van der Zee","year":"2009","journal-title":"Dermatology"},{"issue":"1","key":"srv200006r33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.","volume":"222","author":"Join-Lambert","year":"2011","journal-title":"Dermatology"},{"issue":"2","key":"srv200006r34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000182261","article-title":"Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients\u2019 outcome assessment.","volume":"218","author":"Soria","year":"2009","journal-title":"Dermatology"},{"issue":"1","key":"srv200006r35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","article-title":"Long-term results of acitretin therapy for hidradenitis suppurativa: is acne inversa also a misnomer?","volume":"164","author":"Boer","year":"2011","journal-title":"Br J Dermatol"},{"issue":"4","key":"srv200006r36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0190-9622(99)80077-2","article-title":"Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa.","volume":"41","author":"Jemec","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"srv200006r37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.1986.tb05741.x","article-title":"Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy.","volume":"115","author":"Sawers","year":"1986","journal-title":"Br J Dermatol"},{"issue":"4","key":"srv200006r38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2310\/7750.2007.00019","article-title":"Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy.","volume":"11","author":"Kraft","year":"2007","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"srv200006r39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40257-019-00442-w","article-title":"Is there a role for antiandrogen therapy for hidradenitis suppurativa? a systematic review of published data.","volume":"20","author":"Nikolakis","year":"2019","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"srv200006r40","first-page":"44","article-title":"Finasteride in hidradenitis suppurativa: a \u201cmale\u201d therapy for a predominantly \u201cfemale\u201d disease.","volume":"9","author":"Khandalavala","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"srv200006r41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"srv200006r42","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bjd.14418","article-title":"Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality.","volume":"174","author":"Ingram","year":"2016","journal-title":"Br J Dermatol"},{"issue":"4","key":"srv200006r43","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/bjd.12713","article-title":"Four-weekly infliximab in the treatment of severe hidradenitis suppurativa.","volume":"170","author":"Moriarty","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4","key":"srv200006r44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/09546634.2012.683767","article-title":"Long-term efficacy of infliximab in hidradenitis suppurativa.","volume":"23","author":"Paradela","year":"2012","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"srv200006r45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/09546634.2011.571657","article-title":"Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.","volume":"23","author":"van Rappard","year":"2012","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"srv200006r46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2133.2012.10807.x","article-title":"Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions.","volume":"167","author":"Van Rappard","year":"2012","journal-title":"Br J Dermatol"},{"issue":"8","key":"srv200006r47","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1365-4632.2010.04545.x","article-title":"A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa.","volume":"49","author":"Amano","year":"2010","journal-title":"Int J Dermatol"},{"issue":"12","key":"srv200006r48","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial.","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"issue":"5","key":"srv200006r49","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa.","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"srv200006r50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"issue":"5","key":"srv200006r51","first-page":"s15","article-title":"A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa.","volume":"11","author":"Sotiriou","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"srv200006r52","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jaad.2019.05.022","article-title":"Determining the optimal dose of infliximab for treatment of hidradenitis suppurativa.","volume":"81","author":"Oskardmay","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"srv200006r53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jac\/dkv361","article-title":"Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.","volume":"71","author":"Join-Lambert","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"srv200006r54","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/ijd.14036","article-title":"Ertapenem: a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa.","volume":"57","author":"Braunberger","year":"2018","journal-title":"Int J Dermatol"},{"issue":"5","key":"srv200006r55","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jdcr.2017.12.010","article-title":"Ertapenem rescue therapy in hidradenitis suppurativa.","volume":"4","author":"Chahine","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"8","key":"srv200006r56","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1524-4725.2009.01214.x","article-title":"Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser.","volume":"35","author":"Tierney","year":"2009","journal-title":"Dermatol Surg"},{"issue":"2","key":"srv200006r57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/SAP.0000000000000584","article-title":"Outcomes after combined radical resection and targeted biologic therapy for the management of recalcitrant hidradenitis suppurativa.","volume":"77","author":"DeFazio","year":"2016","journal-title":"Ann Plast Surg"},{"issue":"8","key":"srv200006r58","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/jdv.12952","article-title":"Surgery under general anaesthesia in severe hidradenitis suppurativa: a study of 363 primary operations in 113 patients.","volume":"29","author":"Blok","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"srv200006r59","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/DSS.0000000000000806","article-title":"Surgical management of hidradenitis suppurativa: outcomes of 590 consecutive patients.","volume":"42","author":"Kohorst","year":"2016","journal-title":"Dermatol Surg"},{"issue":"7","key":"srv200006r60","first-page":"827","article-title":"Treatment experience in a local population with hidradenitis suppurativa.","volume":"13","author":"Kohorst","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"srv200006r61","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1524-4725.2011.02255.x","article-title":"Surgical treatment of sinuses by deroofing in hidradenitis suppurativa.","volume":"38","author":"van Hattem","year":"2012","journal-title":"Dermatol Surg"},{"key":"srv200006r19","author":"James","year":"2006"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2769590\/jamasurgery_hamad_2020_rv_200006_1602781336.51381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T20:20:05Z","timestamp":1616962805000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2769590"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2020.2611","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}